Actively Recruiting
AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation
Led by University Hospital Ostrava · Updated on 2023-06-08
480
Participants Needed
9
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A study comparing atrioventricular junction ablation (AVJA) versus continued optimum medical rate control in patients with cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) with suboptimal heart rate control on optimum medication.
CONDITIONS
Official Title
AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Treatment with CRT using either a biventricular pacemaker/defibrillator or conduction system pacemaker for more than 6 months
- Diagnosis of atrial fibrillation classified as permanent or recurrent persistent AF requiring emergency visits or hospitalizations at least once in the past year
- Optimized heart failure medical treatment and rate control medication
- Biventricular pacing percentage plus ventricular premature complex percentage between 85% and less than 99% for at least one month while on optimal medical therapy (for permanent AF patients)
- Age greater than 18 and less than 85 years
- Signed informed consent
You will not qualify if you...
- Myocardial infarction or coronary artery bypass graft within the past 3 months
- Technical failure of the cardiac resynchronization therapy system
- Intentional preference for spontaneous atrioventricular conduction
- Expected survival less than 1 year
- Other significant comorbidities or conditions interfering with trial conduction
- Dementia as assessed by mini-mental test score less than 23 points
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
Regional Hospital Liberec
Liberec, Liberec Region, Czechia, 460 01
Actively Recruiting
2
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia, 70852
Actively Recruiting
3
Hospital Podlesí, Inc.
Třinec, Moravian-Silesian Region, Czechia, 739 61
Actively Recruiting
4
University Hospital Olomouc
Olomouc, Olomouc Region, Czechia, 779 00
Actively Recruiting
5
Hospital České Budějovice
České Budějovice, South Bohemian Region, Czechia, 370 01
Actively Recruiting
6
St. Anne's University Hospital Brno
Brno, South Moravian, Czechia, 602 00
Actively Recruiting
7
University Hospital Brno
Brno, South Moravian, Czechia, 625 00
Actively Recruiting
8
Institute of Clinical and Experimental Medicine
Prague, Czechia, 14021
Actively Recruiting
9
Military University Hospital Prague
Prague, Czechia, 169 02
Actively Recruiting
Research Team
J
Jiří Hynčica
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here